[g-Cyclodextrin](1).[Fluorescein] |
1.54 |
|
|
|
Induced circular dichroism absorption spectroscopy and steady-state and picosecond time resolved fluorescence spectroscopy |
Flamigni, Lucia 1993 |
[g-Cyclodextrin](1).[Fluorescein] |
2.30 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Erythrosine B] |
2.04 |
|
|
|
Induced circular dichroism absorption spectroscopy and steady-state and picosecond time resolved fluorescence spectroscopy |
Flamigni, Lucia 1993 |
[g-Cyclodextrin](1).[Rose bengal] |
2.00 |
|
|
|
Induced circular dichroism absorption spectroscopy and steady-state and picosecond time resolved fluorescence spectroscopy |
Flamigni, Lucia 1993 |
[g-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] |
2.89 |
|
7.2 |
25.0 |
Higuchi and Connors solubility method |
Shehatta, Ibrahim 2002 |
[g-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] |
2.89 |
|
7.5 |
25.0 |
Higuchi and Connors solubility method |
Shehatta, Ibrahim 2002 |
[g-Cyclodextrin].[phenol] |
1.60 |
0.78 |
|
25.0 |
near-infrared spectrometry |
Tran, Chieu D. 2002 |
[g-Cyclodextrin].[7-methoxycoumarin] |
1.61 |
0.90 |
|
|
fluorescence suppression |
Wagner, Brian D. 2003 |
[g-Cyclodextrin](1).[1-b-D ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide] |
3.07 |
|
4.6 |
18.0 |
HPLC |
Kedzierewicz, F. 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.52 |
4.60 |
4.5 |
25.0 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.65 |
4.70 |
5.5 |
25.0 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.74 |
4.70 |
7.4 |
25.0 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.72 |
4.70 |
9.5 |
25.0 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.76 |
4.78 |
7.4 |
20.2 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.74 |
4.70 |
7.4 |
25.1 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.71 |
4.70 |
7.4 |
30.1 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[gymnemic acid] |
5.71 |
4.60 |
7.4 |
35.1 |
isothermal titration calorimetry |
Oda, Masayuki 2005 |
[g-Cyclodextrin](1).[L-tryptophan] |
1.95 |
0.07 |
7.2 |
25.0 |
Calorimetry |
Yu Liu 1998 |
[g-Cyclodextrin](1).[L-tryptophan] |
2.29 |
1.34 |
8.0 |
18.0 |
UV-vis spectroscopy |
Andrzej Temeriusz 2006 |
[g-Cyclodextrin](1).[Disodium 2,7-naphthalenedisulfonate] |
2.58 |
0.02 |
7.2 |
25.0 |
Calorimetry |
Yu Liu 1998 |
[g-Cyclodextrin](1).[Costa-type complex (R=n-C6H13)] |
2.80 |
|
|
25.0 |
1H-NMR |
Hui-Lan Chen 2003 |
[g-Cyclodextrin](1).[Ebselen] |
2.00 |
|
7.0 |
25.0 |
phase solubility |
Kaneto Uekama 2002 |
[g-Cyclodextrin](1).[Cyproterone acetate] |
3.82 |
|
|
25.0 |
phase solubility |
Sandrine Henry De Hassonville 2002 |
[g-Cyclodextrin](2).[Cyproterone acetate] |
1.08 |
|
|
25.0 |
phase solubility |
Sandrine Henry De Hassonville 2002 |
[g-Cyclodextrin](1).[N-(1-adamantylmethyl)-] |
2.81 |
1.70 |
7.0 |
25.0 |
surface plasmon resonance (SPR) |
Susan E. Brown 2003 |
[g-Cyclodextrin](1).[N-octyl-] |
2.30 |
|
7.0 |
25.0 |
surface plasmon resonance (SPR) |
Susan E. Brown 2003 |
[g-Cyclodextrin](1).[N-(4-tert-butyl benzyl)-] |
2.30 |
|
7.0 |
25.0 |
surface plasmon resonance (SPR) |
Susan E. Brown 2003 |
[g-Cyclodextrin](1).[N-(1-pyrenyl methyl)-] |
2.30 |
|
7.0 |
25.0 |
surface plasmon resonance (SPR) |
Susan E. Brown 2003 |
[g-Cyclodextrin](1).[Di-tert-butyl nitroxide ] |
2.43 |
|
|
25.0 |
ESR |
Yoshimi Sueishi 1991 |
[g-Cyclodextrin](1).[2,3-naphthalimide] |
1.78 |
|
7.0 |
25.0 |
UV and fluorescence spectroscopy |
Mario J. Politi 1997 |
[g-Cyclodextrin](1).[2,3-N-butylnaphthalimide] |
2.41 |
|
7.0 |
25.0 |
UV and fluorescence spectroscopy |
Mario J. Politi 1997 |
[g-Cyclodextrin](1).[1,8-naphthalimide] |
1.78 |
|
7.0 |
25.0 |
UV and fluorescence spectroscopy |
Mario J. Politi 1997 |
[g-Cyclodextrin](1).[1,8-N-butylnaphthalimide] |
1.85 |
|
7.0 |
25.0 |
UV and fluorescence spectroscopy |
Mario J. Politi 1997 |
[g-Cyclodextrin](1).[spironolactone] |
4.00 |
|
|
|
phase solubility |
Kaneto Uekama 1997 |
[g-Cyclodextrin](1).[spironolactone] |
3.68 |
|
2.0 |
25.0 |
HPLC-method |
Valentino J. Stella 2000 |
[g-Cyclodextrin](1).[glycyrrhetinic acid] |
1.20 |
0.38 |
7.0 |
|
Higuchi and Connors method |
Noelle Martine Gosselet 2002 |
[g-Cyclodextrin](1).[Parsol MCX] |
3.17 |
2.34 |
7.0 |
|
Higuchi and Connors method |
Noelle Martine Gosselet 2002 |
[g-Cyclodextrin](1).[2-methylnaphthoate] |
2.33 |
1.98 |
|
|
steady-state fluorescence measurement |
Francisco Mendicuti 1999 |
[g-Cyclodextrin](1).[2-methylnaphthoate] |
2.41 |
2.30 |
|
5.0 |
steady-state fluorescence spectroscopy |
Wayne L. Mattice 1998 |
[g-Cyclodextrin](1).[2-methylnaphthoate] |
2.43 |
2.28 |
|
15.0 |
steady-state fluorescence spectroscopy |
Wayne L. Mattice 1998 |
[g-Cyclodextrin](1).[2-methylnaphthoate] |
2.32 |
2.00 |
|
25.0 |
steady-state fluorescence spectroscopy |
Wayne L. Mattice 1998 |
[g-Cyclodextrin](1).[2-methylnaphthoate] |
2.20 |
1.95 |
|
35.0 |
steady-state fluorescence spectroscopy |
Wayne L. Mattice 1998 |
[g-Cyclodextrin](1).[2-methylnaphthoate] |
2.23 |
1.78 |
|
45.0 |
steady-state fluorescence spectroscopy |
Wayne L. Mattice 1998 |
[g-Cyclodextrin](1).[Sodium fusidate] |
4.78 |
4.38 |
|
|
1H and 13C NMR |
Wajih Al-Soufi 2003 |
[g-Cyclodextrin](1).[Potassium helvolate] |
4.34 |
3.95 |
|
|
1H and 13C NMR |
Wajih Al-Soufi 2003 |
[g-Cyclodextrin](1).[propranolol] |
1.94 |
1.48 |
7.0 |
25.0 |
Calorimetry |
Giuseppina Castronuovo 2006 |
[g-Cyclodextrin](1).[propranolol] |
1.89 |
0.90 |
1.3 |
25.0 |
Calorimetry |
Giuseppina Castronuovo 2006 |
[g-Cyclodextrin](1).[2-Acetylnaphthalene] |
2.03 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1-Adamantanecarboxylic acid] |
4.38 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1-Adamantanecarboxylic acid anion] |
3.48 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Adiphenine] |
2.61 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[4-Aminonaphthalene-1-sulfonate anion] |
1.31 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1-Anilinonaphthalene-8-sulfonate anion] |
2.45 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Anthracene] |
3.18 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Beclomethasone dipropionate] |
3.80 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Bencyclane] |
3.60 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Benz[a]anthracene] |
2.78 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Benzene] |
0.96 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Benzophenone] |
2.23 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Benzo[a]pyrene] |
4.81 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Benzoyltrifluoroacetone] |
2.20 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Betamethasone] |
4.33 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Betamethasone] |
3.50 |
2.30 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Betamethasone 17-valerate] |
3.99 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Bromazepam] |
1.49 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Bromazepam] |
1.49 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Bromcresol Green anion] |
3.49 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Bromobenzene] |
1.59 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Bromodiphenhydramine] |
3.39 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Chlorcyclizine] |
3.11 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Chlordiazepoxide] |
2.15 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Chlordiazepoxide] |
2.15 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Chlorobenzene] |
1.52 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cinnarizine] |
1.89 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Clobazam] |
1.56 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Clonazepam] |
1.76 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Congo Red] |
4.24 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cortisone] |
3.34 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cortisone acetate] |
3.39 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[o-Cresolphthalein] |
2.18 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Crystal Violet] |
2.67 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Crystal Violet] |
3.77 |
|
6.0 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2002 |
[g-Cyclodextrin](1).[Cyclizine] |
2.86 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cyclodecane] |
3.04 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cycloheptane] |
1.20 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cyclohexane] |
1.04 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cyclooctane] |
1.85 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Cyclopentane] |
0.48 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Daunorubicin] |
2.51 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Dexamethasone] |
4.42 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Dexamethasone] |
3.56 |
2.30 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Dexamethasone acetate] |
4.57 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Diazepam] |
2.08 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Diazepam] |
2.08 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[1,4-Dibromobenzene] |
1.68 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Di-t-butyl nitroxide] |
2.45 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,4-Dichlorobenzene] |
1.63 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Diethylethylphosphonate] |
1.45 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Diflunisal anion] |
4.74 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,4-Difluorobenzene] |
1.45 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,3-Dihydroxybenzene] |
1.33 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,4-Diiodobenzene] |
1.91 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,4-Dimethylnaphthalene] |
1.00 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,5-Dimethylnaphthalene] |
3.00 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,8-Dimethylnaphthalene] |
2.23 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Diphenidol] |
2.57 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Diphenylhydantoin] |
2.17 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Diphenylpyraline] |
2.89 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Dodecylsulfate anion] |
2.92 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Doxorubicin] |
2.87 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Doxorubicin anion] |
2.83 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Ellipticine] |
4.01 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Emetine] |
2.92 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Ethylbenzene] |
1.56 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Ferrocenemonocarboxylic acid anion] |
2.34 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Fludiazepam] |
2.28 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Fludiazepam] |
2.28 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Flunitrazepam] |
1.60 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Fluocinolone acetonide] |
4.50 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Fluorene] |
2.25 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Fluorobenzene] |
1.15 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Flurazepam] |
2.11 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Flurbiprofen] |
2.66 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Flurbiprofen anion] |
3.48 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[n-Heptane] |
1.48 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[n-Hexane] |
1.04 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Hydrocortisone] |
3.35 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Hydrocortisone acetate] |
3.36 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Hydrocortisone butyrate] |
3.46 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Hydroxyzine] |
3.12 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Iodobenzene] |
1.48 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Isopropylbenzene] |
1.97 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Khellin] |
1.41 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Lorazepam] |
2.15 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Meclizine] |
2.93 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Medazepam] |
2.20 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Medazepam] |
2.20 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Menadione] |
2.00 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1-Methylnaphthalene] |
2.11 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[2-Methylnaphthalene] |
2.18 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Methyl Orange] |
2.00 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Methyl Orange anion] |
1.65 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Mitomycin C] |
2.50 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Naphthacene] |
3.23 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Naphthalene] |
2.11 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[2,7-Naphthalenedisulfonate] |
2.58 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[2-Naphthalenesulfonate anion] |
1.58 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[2-Naphthol] |
1.72 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[a-Naphtholphthalein] |
3.11 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[2-Naphthoyltrifluoroacetone] |
3.12 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Nimetazepam] |
1.58 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Nitrazepam] |
1.52 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[4-Nitrophenol] |
1.79 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[4-Nitrophenol anion] |
2.08 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[3-Nitrophenyl acetate] |
1.48 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[4-Nitrophenyl acetate] |
1.94 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[S-Nitroso-N-acetylpenicillamine] |
1.59 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Nocloprost] |
2.79 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[n-Nonane] |
2.00 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[n-Octane] |
1.79 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1-Octanol] |
3.23 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1-Octanol] |
1.83 |
0.60 |
|
25.0 |
GC |
Isao Sanemasa 1999 |
[g-Cyclodextrin](1).[Orphenadrine] |
2.98 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Oxazepam] |
1.65 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[n-Pentane] |
0.78 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Perfluoro-n-butyric acid anion] |
1.04 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Perfluoro-n-heptanoic acid anion] |
2.62 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Perfluoro-n-nonanoic acid anion] |
3.04 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Perfluoro-n-octanoic acid anion] |
2.88 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Phenanthrene] |
2.89 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Phenolphthalein] |
3.27 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Phloridzin] |
2.61 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Prednisolone] |
3.51 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Prednisolone] |
2.99 |
1.78 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Prednisolone acetate] |
3.59 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Prednisolone acetate] |
3.14 |
1.78 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Proadifen] |
3.05 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Progesterone] |
4.38 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[n-Propylbenzene] |
1.72 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Pyrene] |
2.40 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Rhodamine B] |
1.85 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Testosterone] |
4.22 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Tetrabromophenolphthalein] |
3.78 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Tetradecyltrimethylammonium] |
3.36 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Toluene] |
1.30 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[2-Toluidinylnaphthalene-6-sulfonate anion] |
2.04 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Triamcinolone] |
3.59 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Triamcinolone acetonide] |
4.42 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Triamcinolone diacetate] |
4.08 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,2,3-Trimethylbenzene] |
2.46 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,2,4-Trimethylbenzene] |
1.72 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[1,3,5-Trimethylbenzene] |
1.38 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[Tropaeolin anion] |
2.62 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[o-Xylene] |
1.53 |
|
|
25.0 |
|
Kenneth A. Connors 1995 |
[g-Cyclodextrin](1).[{(+)-(3S,4R)-3-ethyl-4-[(1-methyl.5-imidazolyl)-metyl]-tetrahydrofuran-2-on}] |
1.95 |
0.04 |
7.0 |
25.0 |
Potentiometry |
Lajos Barcza 2006 |
[g-Cyclodextrin](1).[chiral N-imidazole derivative 1 (R enantiomer)] |
1.35 |
|
|
29.0 |
NMR spectroscopy |
Claude Vaccher 2006 |
[g-Cyclodextrin](1).[chiral N-imidazole derivative 1 (S enantiomer)] |
1.12 |
|
|
30.0 |
NMR spectroscopy |
Claude Vaccher 2006 |
[g-Cyclodextrin](2).[azulene] |
5.65 |
4.93 |
7.0 |
25.0 |
Absorption and fluorescence spectroscopy, induced-cirular dicroism spectroscopy |
Osama K. Abou-Zied 2005 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.28 |
2.60 |
7.5 |
25.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.15 |
2.48 |
7.5 |
30.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.04 |
2.48 |
7.5 |
37.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.85 |
2.95 |
|
15.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.57 |
2.78 |
|
20.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.56 |
2.70 |
|
25.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.60 |
3.00 |
|
30.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[phenylbutazone] |
3.39 |
1.00 |
|
37.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[oxyphenbutazone] |
3.04 |
1.30 |
|
15.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[oxyphenbutazone] |
2.38 |
1.48 |
|
20.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[oxyphenbutazone] |
2.51 |
1.60 |
|
25.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[oxyphenbutazone] |
2.69 |
1.95 |
|
30.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[oxyphenbutazone] |
2.70 |
2.00 |
|
37.0 |
UV-vis spectroscopy |
David Diaz 1998 |
[g-Cyclodextrin](1).[20(S)-Camptothecin] |
1.86 |
|
1.7 |
25.0 |
HPLC-method |
Vijay Kumar 2002 |
[g-Cyclodextrin](1).[Bis( 2-pyridylcarbinolato)copper(II)] |
6.26 |
|
7.0 |
|
ESR spectroscopy |
Hiroshi Yokoi 1991 |
[g-Cyclodextrin](1).[Ro 28-2653] |
2.54 |
|
7.0 |
37.0 |
HPLC-method |
Bertholet Pascal 2005 |
[g-Cyclodextrin](1).[pyrene] |
1.30 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Takehlko Yorozu 1982 |
[g-Cyclodextrin](0.5).[pyrene] |
6.70 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Takehlko Yorozu 1982 |
[g-Cyclodextrin](2).[pyrene] |
2.30 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Takehlko Yorozu 1982 |
[g-Cyclodextrin](1).[2-naphthalenesul fonate] |
1.58 |
0.03 |
7.2 |
25.0 |
Calorimetry |
Yoshihisa Inoue 1993 |
[g-Cyclodextrin](2).[2-naphthalenesul fonate] |
2.59 |
0.07 |
7.2 |
25.0 |
Calorimetry |
Yoshihisa Inoue 1993 |
[g-Cyclodextrin](1).[2,7-naphthalenedisulfonate ] |
2.58 |
0.02 |
7.2 |
25.0 |
Calorimetry |
Yoshihisa Inoue 1993 |
[g-Cyclodextrin](1).[4-amino-1-naphthalenesulfonate] |
1.31 |
0.08 |
7.2 |
25.0 |
Calorimetry |
Yoshihisa Inoue 1993 |
[g-Cyclodextrin](1).[risperidone] |
2.16 |
|
10.5 |
25.0 |
UV-Vis spectroscopy |
M.B. Zughul 2005 |
[g-Cyclodextrin](1).[9-methylanthracene] |
3.23 |
2.48 |
|
25.0 |
Fluorescence spectroscopy |
Vincent C. Reinsborough 1995 |
[g-Cyclodextrin](2).[manganese(III) tetrakis(4-sulfonatopheny1)porphine] |
1.61 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
Robert G. Bryant 1995 |
[g-Cyclodextrin](1).[2-[ (p-amino)phenyl]-3,3-dimethyl-5-cyano-3H-indole] |
3.09 |
|
9.5 |
25.0 |
Fluorescence spectroscopy |
Gilles Durocher 1997 |
[g-Cyclodextrin](2).[2-[ (p-amino)phenyl]-3,3-dimethyl-5-cyano-3H-indole] |
1.20 |
|
9.5 |
25.0 |
Fluorescence spectroscopy |
Gilles Durocher 1997 |
[g-Cyclodextrin](1).[2-[ (p-dimethylamino)phenyll-3,3-dimethyl-5-cyano-3H-indole] |
3.89 |
|
9.5 |
25.0 |
Fluorescence spectroscopy |
Gilles Durocher 1997 |
[g-Cyclodextrin](2).[2-[ (p-dimethylamino)phenyll-3,3-dimethyl-5-cyano-3H-indole] |
1.60 |
|
9.5 |
25.0 |
Fluorescence spectroscopy |
Gilles Durocher 1997 |
[g-Cyclodextrin](1).[12-crown-4] |
1.04 |
|
7.6 |
25.0 |
NMR diffusion measurements |
Yoram Cohen 1997 |
[g-Cyclodextrin](1).[12-crown-4] |
1.32 |
|
2.0 |
25.0 |
NMR diffusion measurements |
Yoram Cohen 1997 |
[g-Cyclodextrin](1).[12-crown-4] |
1.49 |
|
14.0 |
25.0 |
NMR diffusion measurements |
Yoram Cohen 1997 |
[g-Cyclodextrin](1).[12-crown-4] |
1.00 |
|
|
25.0 |
NMR diffusion measurements |
Yoram Cohen 1997 |
[g-Cyclodextrin](1).[cyclen] |
1.28 |
|
7.6 |
25.0 |
NMR diffusion measurements |
Yoram Cohen 1997 |
[g-Cyclodextrin](1).[1,4,7,10-tetrathiacyclododecane] |
1.32 |
|
|
25.0 |
NMR diffusion measurements |
Yoram Cohen 1997 |
[g-Cyclodextrin](1).[glisentide] |
2.16 |
0.90 |
4.2 |
15.0 |
UV-vis spectroscopy |
A. Zornoza 1998 |
[g-Cyclodextrin](1).[glisentide] |
1.99 |
0.70 |
4.2 |
25.0 |
UV-vis spectroscopy |
A. Zornoza 1998 |
[g-Cyclodextrin](1).[glisentide] |
1.93 |
0.60 |
4.2 |
30.0 |
UV-vis spectroscopy |
A. Zornoza 1998 |
[g-Cyclodextrin](1).[glisentide] |
1.82 |
0.48 |
4.2 |
37.0 |
UV-vis spectroscopy |
A. Zornoza 1998 |
[g-Cyclodextrin](1).[(-)-N-(benzo[b]thien-2-ylethyl) N-hydroxyurea] |
3.41 |
2.34 |
7.0 |
25.0 |
NMR spectroscopy |
M. Cotta Ramusino 1998 |
[g-Cyclodextrin](1).[(-)-N-(benzo[b]thien-2-ylethyl) N-hydroxyurea] |
3.23 |
2.26 |
7.0 |
25.0 |
UV-vis spectroscopy |
M. Cotta Ramusino 1998 |
[g-Cyclodextrin](1).[(-)-N-(benzo[b]thien-2-ylethyl) N-hydroxyurea] |
3.20 |
2.48 |
7.0 |
25.0 |
Circular dichroism spectroscopy |
M. Cotta Ramusino 1998 |
[g-Cyclodextrin](1).[chlorpromazine hydrochloride] |
2.62 |
|
7.4 |
37.0 |
Surface tension |
Noriaki Funasaki 1999 |
[g-Cyclodextrin](1).[chlorpromazine hydrochloride] |
3.00 |
|
|
25.0 |
UV-vis spectroscopy |
Noriaki Funasaki 1999 |
[g-Cyclodextrin](1).[propantheline bromide] |
2.36 |
|
|
37.0 |
Surface tension |
Noriaki Funasaki 1999 |
[g-Cyclodextrin](0.5).[propantheline bromide] |
1.85 |
|
|
37.0 |
Surface tension |
Noriaki Funasaki 1999 |
[g-Cyclodextrin](1).[indomethacin] |
2.43 |
1.60 |
10.0 |
40.0 |
HPLC-method |
Thorsteinn Loftsson 1999 |
[g-Cyclodextrin](1).[chlorambucil] |
2.54 |
1.00 |
7.5 |
30.0 |
HPLC-method |
Thorsteinn Loftsson 1999 |
[g-Cyclodextrin](1).[chlorambucil] |
3.49 |
2.69 |
4.15 |
37.0 |
UV spectroscopy |
Yannis L. Loukas 1997 |
[g-Cyclodextrin](1).[Benzyl tert-butyl nitroxide] |
1.71 |
|
7.0 |
21.0 |
EPR spectroscopy |
Marco Lucarini 2004 |
[g-Cyclodextrin](1).[benzo-15-crown-5 ether derivative] |
1.78 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Norio Teramae 2000 |
[g-Cyclodextrin](0.5).[benzo-15-crown-5 ether derivative] |
5.82 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Norio Teramae 2000 |
[g-Cyclodextrin](2).[benzo-15-crown-5 ether derivative] |
2.53 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Norio Teramae 2000 |
[g-Cyclodextrin](1).[dibenzyl nitroxide] |
1.83 |
|
7.0 |
21.0 |
EPR spectroscopy |
Marco Lucarini 2004 |
[g-Cyclodextrin](1).[di-tert amyl nitroxide] |
2.41 |
|
7.0 |
21.0 |
EPR spectroscopy |
Marco Lucarini 2004 |
[g-Cyclodextrin](1).[Fe(III)-tetrakis(sulfonatophenyl)porphyrin] |
0.64 |
0.08 |
6.0 |
25.0 |
UV-Vis spectroscopy |
Masami Fukushima 2006 |
[g-Cyclodextrin](1).[pancreatic a-amylase] |
2.54 |
|
6.9 |
30.0 |
UV-vis spectroscopy |
Roger Koukiekolo 2001 |
[g-Cyclodextrin](1).[tetrakis(sulfonatophenyl)porphyrin] |
0.87 |
0.02 |
6.0 |
25.0 |
UV-Vis spectroscopy |
Masami Fukushima 2006 |
[g-Cyclodextrin](1).[Pb(II) nitrate] |
2.89 |
1.03 |
|
|
Cyclic voltammetry |
Maria Teresa Ramirez-Silva 2005 |
[g-Cyclodextrin](1).[eugenol] |
5.17 |
|
7.0 |
20.0 |
UV-vis spectroscopy |
Le Xin Song 2005 |
[g-Cyclodextrin](1).[diflunisal] |
4.74 |
3.30 |
7.0 |
25.0 |
UV-vis spectroscopy |
John H. Coates 1988 |
[g-Cyclodextrin](2).[diflunisal] |
4.36 |
3.30 |
7.0 |
25.0 |
NMR spectroscopy |
John H. Coates 1988 |
[g-Cyclodextrin](1).[Rocuronium Bromide] |
4.26 |
3.30 |
|
30.0 |
NMR spectroscopy |
Lee Fielding 2002 |
[g-Cyclodextrin](1).[NADH] |
0.37 |
|
6.0 |
25.0 |
HPLC-method |
Manabu Seno 1990 |
[g-Cyclodextrin](1).[NADP] |
0.49 |
|
6.0 |
25.0 |
HPLC-method |
Manabu Seno 1990 |
[g-Cyclodextrin](1).[Gd-1] |
4.97 |
|
7.0 |
25.0 |
Proton Relaxation Enhancement Method |
Silvio Aime 2006 |
[g-Cyclodextrin](1).[(S)-(+)-6-methoxy-a-methyl-2-naphthaleneacetic acid] |
2.58 |
0.05 |
2.5 |
20.0 |
Fluorescence spectroscopy |
Graciela M. Escandar 2001 |
[g-Cyclodextrin](1).[(S)-(+)-6-methoxy-a-methyl-2-naphthaleneacetic acid] |
2.47 |
0.07 |
10.0 |
20.0 |
Fluorescence spectroscopy |
Graciela M. Escandar 2001 |
[g-Cyclodextrin](1).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] |
2.36 |
1.48 |
|
|
Fluorescence spectroscopy |
Athena Kasselouri 1999 |
[g-Cyclodextrin](2).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] |
4.38 |
3.08 |
|
|
Fluorescence spectroscopy |
Athena Kasselouri 1999 |
[g-Cyclodextrin](1).[Nitrazepam ] |
1.52 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Nimetazepam ] |
1.58 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Flunitrazepam ] |
1.60 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](2).[Flunitrazepam ] |
0.30 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Pindolol] |
1.58 |
0.85 |
12.0 |
25.0 |
HPLC-method |
Arantza Zornoza 2005 |
[g-Cyclodextrin](1).[Clonazepam ] |
1.76 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Flurazepam ] |
2.11 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Lorazepam ] |
2.15 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[oxazepam ] |
1.65 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[Clobazam ] |
1.56 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
M. Otagiri 1983 |
[g-Cyclodextrin](1).[( 5Z, 13E)-(9R, 11 R, 15R)-9-chloro-11,15-dihydroxy-16,16-dimethyl-5,13-prostadienoic acid] |
2.99 |
|
7.0 |
15.0 |
UV-vis spectroscopy |
Kaneto Uekama 1990 |
[g-Cyclodextrin](1).[( 5Z, 13E)-(9R, 11 R, 15R)-9-chloro-11,15-dihydroxy-16,16-dimethyl-5,13-prostadienoic acid] |
2.79 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
Kaneto Uekama 1990 |
[g-Cyclodextrin](1).[( 5Z, 13E)-(9R, 11 R, 15R)-9-chloro-11,15-dihydroxy-16,16-dimethyl-5,13-prostadienoic acid] |
2.64 |
|
7.0 |
35.0 |
UV-vis spectroscopy |
Kaneto Uekama 1990 |
[g-Cyclodextrin](1).[2-dibenzofuran carboxylate] |
2.78 |
2.30 |
10.0 |
27.0 |
NMR spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](0.5).[2-dibenzofuran carboxylate] |
3.85 |
3.30 |
10.0 |
27.0 |
NMR spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](1).[doxorubicin] |
2.81 |
|
1.5 |
25.0 |
HPLC-method |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.30 |
|
1.5 |
50.0 |
HPLC-method |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.78 |
|
1.5 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.51 |
|
1.5 |
50.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.78 |
|
3.0 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.46 |
|
3.0 |
50.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.83 |
|
7.0 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.79 |
|
10.0 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[doxorubicin] |
2.85 |
|
10.0 |
25.0 |
UV-vis spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.69 |
|
1.5 |
25.0 |
HPLC-method |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.32 |
|
1.5 |
50.0 |
HPLC-method |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.75 |
|
1.5 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.60 |
|
1.5 |
50.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.73 |
|
3.0 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.59 |
|
3.0 |
50.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.89 |
|
7.0 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.76 |
|
10.0 |
25.0 |
Circular dichroism spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[daunorubicin] |
2.81 |
|
10.0 |
25.0 |
UV-vis spectroscopy |
W. J. M. Underberg 1990 |
[g-Cyclodextrin](1).[hydrocortisone butyrate ] |
3.52 |
|
4.0 |
20.0 |
Solubility method (UV-vis spectroscopy) |
In Koo Chun 1993 |
[g-Cyclodextrin](1).[hydrocortisone butyrate ] |
3.41 |
|
4.0 |
30.0 |
Solubility method (UV-vis spectroscopy) |
In Koo Chun 1993 |
[g-Cyclodextrin](1).[hydrocortisone butyrate ] |
3.32 |
|
4.0 |
37.0 |
Solubility method (UV-vis spectroscopy) |
In Koo Chun 1993 |
[g-Cyclodextrin](1).[hydrocortisone butyrate ] |
3.31 |
|
4.0 |
25.0 |
Circular dichroism spectroscopy |
In Koo Chun 1993 |
[g-Cyclodextrin](1).[hydrocortisone butyrate ] |
3.17 |
|
4.0 |
25.0 |
UV-vis spectroscopy |
In Koo Chun 1993 |
[g-Cyclodextrin](1).[sodium decanoate] |
1.48 |
0.85 |
7.0 |
20.0 |
NMR spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](1).[Diphenidol HCl] |
2.57 |
1.02 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Orphenadrine HCI ] |
2.98 |
2.06 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Bromodiphenhydramine HCl ] |
3.39 |
1.70 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Diphenylpyraline HCI ] |
2.89 |
1.29 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Cyclizine HCl] |
2.86 |
1.26 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Chlorcyclizine HCI] |
3.11 |
1.71 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Chlorcyclizine 2HCl] |
3.04 |
1.56 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Meclizine 2HCl] |
2.93 |
1.07 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Hydroxyzine HCI] |
3.08 |
1.78 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Hydroxyzine 2HCl ] |
3.12 |
1.96 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Proadifen HCl] |
3.05 |
1.70 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Adiphenine HCl ] |
2.61 |
0.88 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[Cinnarizine 2HCl] |
1.89 |
0.26 |
7.0 |
25.0 |
Calorimetry |
Bradley D. Anderson 1993 |
[g-Cyclodextrin](1).[fenoprofen calcium dihydrate] |
1.72 |
0.29 |
7.4 |
25.0 |
UV-vis spectroscopy |
David Diaz 1999 |
[g-Cyclodextrin](1).[fenoprofen calcium dihydrate] |
1.80 |
-0.29 |
7.4 |
25.0 |
Fluorescence spectroscopy |
David Diaz 1999 |
[g-Cyclodextrin](1).[tryptophan] |
1.08 |
0.78 |
7.0 |
30.0 |
NMR spectroscopy |
Akira Harada 2006 |
[g-Cyclodextrin](1).[phenylalanine] |
0.48 |
|
7.0 |
30.0 |
NMR spectroscopy |
Akira Harada 2006 |
[g-Cyclodextrin](1).[poly(N-methacryloyltryptophan)] |
1.30 |
0.30 |
7.0 |
25.0 |
Fluorescence spectroscopy |
Akira Harada 2006 |
[g-Cyclodextrin](1).[poly(N-methacryloyltryptophan)] |
1.04 |
0.30 |
7.0 |
30.0 |
NMR spectroscopy |
Akira Harada 2006 |
[g-Cyclodextrin](1).[lanthanide (III) chelates of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylenephosphonate] |
1.20 |
0.30 |
7.0 |
25.0 |
Isothermal calorimetry |
Margarida Bastos 2003 |
[g-Cyclodextrin](1).[lanthanide (III) chelates of 1,4,7,10-tertraazacyclododecane-1,4,7,10-tetraacetate] |
1.00 |
0.30 |
7.0 |
25.0 |
Isothermal calorimetry |
Margarida Bastos 2003 |
[g-Cyclodextrin](1).[R-18-T5] |
1.71 |
0.48 |
|
|
|
George W. Gokel 2003 |
[g-Cyclodextrin](1).[S-18-T5] |
1.61 |
|
|
|
|
George W. Gokel 2003 |
[g-Cyclodextrin](1).[(P)-1,12-dimethylbenzo[c]phenantrene-5,8-dicarboxylic acid] |
3.49 |
2.00 |
7.0 |
25.0 |
NMR spectroscopy |
George W. Gokel 2003 |
[g-Cyclodextrin](1).[(M)-1,12-dimethylbenzo[c]phenantrene-5,8-dicarboxylic acid] |
2.84 |
1.30 |
7.0 |
25.0 |
NMR spectroscopy |
George W. Gokel 2003 |
[g-Cyclodextrin](2).[2-anthracenecarboxylate] |
6.90 |
5.36 |
9.1 |
25.0 |
HPLC method |
Hiroshi Ikeda 2005 |
[g-Cyclodextrin](1).[p-Xylene] |
1.53 |
|
|
25.0 |
|
Toshio Shinbo 2004 |
[g-Cyclodextrin](1).[butyric acid] |
0.52 |
0.04 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[valeric acid] |
1.13 |
|
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[isovaleric acid] |
1.33 |
0.53 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[succinic acid] |
0.82 |
0.51 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[succinic acid] |
0.41 |
-0.22 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[cadaverine] |
1.05 |
0.36 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[putrescine] |
1.18 |
0.23 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[pyridine ] |
1.28 |
0.26 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[3-methyl-pyridine] |
1.46 |
0.51 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[diphenylamine] |
1.76 |
0.89 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[hydrogen sulfide] |
0.70 |
-0.08 |
|
22.0 |
HS-GCMS |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[methanethiol] |
0.40 |
-1.00 |
|
22.0 |
HS-GCMS |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[dimethyl sulfide] |
0.92 |
-0.35 |
|
22.0 |
HS-GCMS |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[phenyl acetate] |
1.15 |
0.20 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[m-cresol] |
1.99 |
0.91 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[phenol ] |
0.41 |
0.15 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[indole] |
1.32 |
0.30 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[skatole] |
1.47 |
0.46 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[dodecanol] |
1.91 |
1.16 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[tatradecanol] |
1.93 |
1.16 |
7.0 |
22.0 |
NMR titration |
Daniel W. Armstrong 2006 |
[g-Cyclodextrin](1).[ampicillin] |
1.28 |
0.60 |
7.0 |
25.0 |
NMR spectroscopy |
Konstantina Yannakopoulou 2006 |
[g-Cyclodextrin](1).[dicloxacillin] |
2.79 |
2.30 |
7.0 |
25.0 |
NMR spectroscopy |
Konstantina Yannakopoulou 2006 |
[g-Cyclodextrin](1).[styrene] |
2.57 |
|
|
|
|
Kasi Pitchumani 2005 |
[g-Cyclodextrin](1).[methyl cinnamate] |
2.45 |
|
|
|
|
Kasi Pitchumani 2005 |
[g-Cyclodextrin](1).[phenylacetylene] |
2.48 |
|
|
|
|
Kasi Pitchumani 2005 |
[g-Cyclodextrin](1).[allylbenzene] |
2.51 |
|
|
|
|
Kasi Pitchumani 2005 |
[g-Cyclodextrin](1).[cyclosporin A] |
1.82 |
|
7.0 |
25.0 |
HPLC method |
Laura Matilainen 2006 |
[g-Cyclodextrin](1).[salicylidine-3,4,7-methyl amine] |
2.38 |
|
7.0 |
23.0 |
Fluorescence spectroscopy |
S. Mukherjee 2005 |
[g-Cyclodextrin](1).[b-lapachone] |
2.20 |
0.70 |
7.4 |
25.0 |
UV-vis spectroscopy |
Jinming Gao 2003 |
[g-Cyclodextrin](1).[1-{[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d] pyrimidin-5-yl)-4-ethoxyphenyl] sulfonyl}-4-methylpiperazine] |
1.66 |
1.28 |
8.7 |
30.0 |
UV-vis spectroscopy |
Mahmoud M. Al Omari 2006 |
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] |
4.08 |
3.00 |
2.0 |
25.0 |
Fluorescence spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] |
2.70 |
1.78 |
10.0 |
15.0 |
Fluorescence spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] |
2.65 |
1.78 |
10.0 |
25.0 |
Fluorescence spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] |
2.60 |
1.78 |
10.0 |
35.0 |
Fluorescence spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](1).[dibenzofuran-2-carboxylic acid] |
2.48 |
2.00 |
10.0 |
45.0 |
Fluorescence spectroscopy |
Gustavo González-Gaitano 2004 |
[g-Cyclodextrin](0.5).[4-CH3O-Phenol] |
4.15 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](0.5).[Phenol] |
4.08 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](0.5).[4-Br-Phenol] |
5.20 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](0.5).[4-NO2-Phenol] |
5.40 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](0.5).[4-CH3-Phenol] |
6.34 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](0.5).[4-I-Phenol] |
6.43 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](1).[4-(CH3)2CH-Phenol] |
3.23 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](1).[1-Naphthol] |
2.79 |
|
6.9 |
40.0 |
UV-vis spectroscopy |
Yoshimi Sueishi 2003 |
[g-Cyclodextrin](1).[a-ethyl-2,4,6-trimethoxybenzyl tertbutyl nitroxide ] |
1.92 |
|
7.0 |
25.0 |
Electron Paramagnetic Resonance |
Yoshimi Sueishi 2004 |
[g-Cyclodextrin](1).[ketoconazole] |
2.93 |
1.48 |
6.0 |
25.0 |
UV-vis spectroscopy |
Joanna Taraszewska 2005 |
[g-Cyclodextrin](1).[naftifine] |
2.26 |
1.20 |
12.0 |
25.0 |
UV-vis spectroscopy |
Itziar Velaz 2006 |
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] |
6.30 |
5.63 |
7.4 |
5.0 |
Ion selective electrode potentiometry |
P.E. Macheras 1999 |
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] |
5.79 |
5.10 |
7.4 |
15.0 |
Ion selective electrode potentiometry |
P.E. Macheras 1999 |
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] |
4.95 |
3.97 |
7.4 |
25.0 |
Ion selective electrode potentiometry |
P.E. Macheras 1999 |
[g-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] |
4.77 |
4.21 |
7.4 |
37.0 |
Ion selective electrode potentiometry |
P.E. Macheras 1999 |
[g-Cyclodextrin](1).[2,3-diazabicyclo[2.2.2]oct-2-ene] |
0.78 |
0.48 |
7.0 |
25.0 |
NMR spectroscopy |
Werner M. Nau 1999 |
[g-Cyclodextrin](1).[Tb-podate] |
5.30 |
|
7.3 |
20.0 |
Luminescence titrations |
Jean-Claude G. Bünzli 2000 |
[g-Cyclodextrin](1).[beclomethasone] |
2.85 |
|
|
|
HPLC-method |
Nicholas H. Snow 2001 |
[g-Cyclodextrin](1).[betamethasone] |
2.23 |
|
|
|
HPLC-method |
Nicholas H. Snow 2001 |
[g-Cyclodextrin](1).[dexamethasone] |
3.01 |
|
|
|
HPLC-method |
Nicholas H. Snow 2001 |
[g-Cyclodextrin](1).[D9,11-betamethasone] |
3.00 |
|
|
|
HPLC-method |
Nicholas H. Snow 2001 |
[g-Cyclodextrin](1).[α-asarone] |
3.31 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[ferulic acid] |
2.85 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[magnolol] |
3.07 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[honokiol] |
2.93 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[acridine red] |
2.07 |
|
6.0 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2002 |
[g-Cyclodextrin](1).[sodium 6-p-toluidino-2-naphthalenesulfonic acid] |
2.25 |
|
6.0 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2002 |
[g-Cyclodextrin](1).[cinchonidine] |
2.51 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[cinchonine] |
2.66 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[quinine] |
2.34 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[quinidine] |
2.31 |
|
7.2 |
25.0 |
Fluorescence spectroscopy |
Yu Liu 2003 |
[g-Cyclodextrin](1).[atrazine] |
4.28 |
|
7.0 |
|
Polarography |
L. Pospisil 1998 |
[g-Cyclodextrin](1).[Naphtalene-1-sulfonate] |
1.51 |
0.69 |
3.0 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-1-sulfonate] |
1.45 |
|
9.2 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-2-sulfonate] |
1.60 |
0.83 |
3.0 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-2-sulfonate] |
1.52 |
|
9.2 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-1,5-disulfonate] |
1.47 |
0.54 |
3.0 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-1,5-disulfonate] |
1.38 |
|
9.2 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[dansyl-branched saccharide cyclophane] |
2.88 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Osamu Hayashida 2002 |
[g-Cyclodextrin](1).[Naphtalene-1,6-disulfonate] |
1.49 |
0.62 |
3.0 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-1,6-disulfonate] |
1.37 |
|
9.2 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-2,6-disulfonate] |
1.59 |
0.62 |
3.0 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[Naphtalene-2,6-disulfonate] |
1.51 |
|
9.2 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[N-carboxybenzoyl-D-glutamyl-L-tyrosine] |
1.99 |
0.30 |
6.9 |
25.0 |
Isothermal titration calorimetry |
Yoshihisa Inoue 2004 |
[g-Cyclodextrin](1).[N-carboxybenzoyl-L-glutamyl-L-tyrosine] |
1.60 |
0.30 |
6.9 |
25.0 |
Isothermal titration calorimetry |
Yoshihisa Inoue 2004 |
[g-Cyclodextrin](1).[3-aminonaphtalene-2,7-disulfonate] |
1.56 |
0.78 |
3.0 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[3-aminonaphtalene-2,7-disulfonate] |
1.37 |
|
9.2 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[5,10,15-tris(3,5-dicarboxylatophenyl)-20-phenylporphyrin] |
2.81 |
1.48 |
7.0 |
25.0 |
Isothermal titration calorimetry |
Koji Kano 2005 |
[g-Cyclodextrin](1).[(S)-20,30,50-trimethyl-40-hydroxy-a-dodecylthio-phenylacetanilide] |
1.30 |
|
7.0 |
25.0 |
Fluorescence spectroscopy |
Philippe Morin 2005 |
[g-Cyclodextrin](1).[2-aminonaphtalene-1,5-disulfonate] |
1.24 |
0.76 |
3.0 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[2-aminonaphtalene-1,5-disulfonate] |
1.13 |
|
9.2 |
25.0 |
Capillary electrophoresis |
Wang-Hsien Ding 2004 |
[g-Cyclodextrin](1).[rocuronium bromide] |
6.11 |
5.48 |
7.0 |
10.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](1).[rocuronium bromide] |
6.15 |
5.30 |
7.0 |
25.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](1).[rocuronium bromide] |
6.04 |
5.48 |
7.0 |
32.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](1).[rocuronium bromide] |
5.95 |
5.30 |
7.0 |
35.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](1).[rocuronium bromide] |
5.54 |
4.48 |
7.0 |
40.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](0.5).[rocuronium bromide] |
3.60 |
3.18 |
7.0 |
10.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](0.5).[rocuronium bromide] |
3.30 |
2.70 |
7.0 |
25.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](0.5).[rocuronium bromide] |
3.18 |
2.48 |
7.0 |
32.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](0.5).[rocuronium bromide] |
3.11 |
2.23 |
7.0 |
35.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](0.5).[rocuronium bromide] |
2.85 |
2.00 |
7.0 |
40.0 |
Isothermal titration microcalorimetry |
Ronald Palin 2005 |
[g-Cyclodextrin](1).[triclosan] |
1.30 |
|
7.0 |
25.0 |
UV-vis spectroscopy |
P. Mura 2005 |
[g-Cyclodextrin](1).[2-dibenzofuranol] |
-0.48 |
-2.05 |
7.0 |
15.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](1).[2-dibenzofuranol] |
-0.41 |
-1.70 |
7.0 |
25.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](1).[2-dibenzofuranol] |
-0.51 |
-1.70 |
7.0 |
35.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](1).[2-dibenzofuranol] |
-0.62 |
-2.22 |
7.0 |
45.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](0.5).[2-dibenzofuranol] |
1.45 |
-0.30 |
7.0 |
15.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](0.5).[2-dibenzofuranol] |
1.12 |
-0.52 |
7.0 |
25.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](0.5).[2-dibenzofuranol] |
0.87 |
-0.70 |
7.0 |
35.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](0.5).[2-dibenzofuranol] |
1.05 |
-1.00 |
7.0 |
45.0 |
Fluorescence spectroscopy |
Gustavo Gonzalez-Gaitano 2005 |
[g-Cyclodextrin](1).[[(−)-(5R,6S)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-morphinan-6-ol]] |
3.19 |
0.03 |
7.0 |
25.0 |
Potentiometry |
Lajos Barcza 2006 |
[g-Cyclodextrin](1).[sodium-2-naphthalenesulfonate] |
2.63 |
|
|
23.0 |
NIR spectroscopy |
Chieu D. Tran 1995 |
[g-Cyclodextrin](1).[sodium-1-pyrenesulfonate] |
2.00 |
|
|
23.0 |
NIR spectroscopy |
Chieu D. Tran 1995 |
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] |
3.17 |
|
|
35.0 |
HPLC |
Ekaterini Antoniadou-Vyza 1994 |
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] |
3.10 |
|
|
40.0 |
HPLC |
Ekaterini Antoniadou-Vyza 1994 |
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] |
2.94 |
|
|
45.0 |
HPLC |
Ekaterini Antoniadou-Vyza 1994 |
[g-Cyclodextrin](1).[a-(Diethoxyphosphinoximino)dicyclopropylmethane] |
2.85 |
|
|
50.0 |
HPLC |
Ekaterini Antoniadou-Vyza 1994 |
[g-Cyclodextrin](1).[Estradiol] |
3.85 |
2.60 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Ethinyloestradiol] |
4.03 |
2.98 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Estriol] |
3.51 |
2.57 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Estrone] |
3.41 |
2.36 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Nandrolone] |
3.36 |
1.90 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Norethisterone] |
3.72 |
2.36 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Methylprednisolone] |
3.00 |
1.90 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Methylprednisolone acetate] |
3.12 |
1.90 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Betamethasone phosphate] |
3.18 |
2.54 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[Dexamethasone phosphate] |
3.30 |
2.70 |
|
35.0 |
HPLC |
Nina Sadlej-Sosnowska 1997 |
[g-Cyclodextrin](1).[methyl tert-butyl ether] |
2.56 |
|
|
25.0 |
GC |
Ji-Won Yang 2003 |
[g-Cyclodextrin](1).[n-hexane] |
0.46 |
|
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](2).[praziquantel] |
1.18 |
|
|
30.0 |
UV spectroscopy |
Gordon Becket 1999 |
[g-Cyclodextrin](1).[n-heptane] |
1.49 |
1.26 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[n-octane] |
1.23 |
0.78 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[n-nonane] |
0.88 |
0.63 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[n-decane] |
1.30 |
1.26 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[n-dodecane] |
1.56 |
1.34 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[Me-cyclohexane] |
0.95 |
0.70 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[Et-cyclohexane] |
0.90 |
0.30 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[benzene] |
0.94 |
0.94 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[1-Butanol] |
0.30 |
-1.00 |
|
25.0 |
GC |
Isao Sanemasa 1999 |
[g-Cyclodextrin](1).[toluene] |
1.52 |
0.78 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[o-xylene] |
1.76 |
|
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[m-xylene] |
1.26 |
1.08 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[p-xylene] |
1.51 |
1.36 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[Et-benzene] |
2.10 |
1.46 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[1,3,5-trimethyl-benzene] |
1.26 |
0.48 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[1,2,3-trimethyl-benzene] |
2.24 |
1.48 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[1,2,4-trimethyl-benzene] |
0.93 |
0.59 |
|
25.0 |
GC (SHSGC) |
É. Fenyvesi 2005 |
[g-Cyclodextrin](1).[1-Pentanol] |
0.52 |
-0.40 |
|
25.0 |
GC |
Isao Sanemasa 1999 |
[g-Cyclodextrin](1).[2-Pentanol] |
0.49 |
-1.00 |
|
25.0 |
GC |
Isao Sanemasa 1999 |
[g-Cyclodextrin](1).[1-Hexanol] |
1.11 |
|
|
25.0 |
GC |
Isao Sanemasa 1999 |
[g-Cyclodextrin](1).[1-Heptanol] |
1.57 |
0.48 |
|
25.0 |
GC |
Isao Sanemasa 1999 |
[g-Cyclodextrin](1).[1-Nonanol] |
2.15 |
0.30 |
|
25.0 |
GC |
Isao Sanemasa 1999 |
[g-Cyclodextrin](1).[phenolphthalein] |
3.31 |
2.15 |
10.5 |
25.0 |
UV/VIS spectroscopy |
Bruno Szpoganicz 2001 |
[g-Cyclodextrin](1).[decanoate ] |
2.40 |
1.70 |
10.5 |
25.0 |
UV/VIS spectroscopy |
Bruno Szpoganicz 2001 |
[g-Cyclodextrin](1).[octanoate] |
1.67 |
0.30 |
10.5 |
25.0 |
UV/VIS spectroscopy |
Bruno Szpoganicz 2001 |
[g-Cyclodextrin](1).[tetradecyltrimethylammonium bromide] |
2.75 |
1.63 |
|
25.0 |
Potentiometric titration |
Toshihiro Tominaga 1994 |
[g-Cyclodextrin](0.5).[tetradecyltrimethylammonium bromide] |
3.75 |
2.99 |
|
25.0 |
Potentiometric titration |
Toshihiro Tominaga 1994 |
[g-Cyclodextrin](1).[4,4’-bipyridine] |
1.65 |
|
|
25.0 |
stopped-flow spectrophotometry |
R.Prado-Gotor 2006 |
[g-Cyclodextrin](1).[norflurazon] |
1.57 |
0.23 |
|
25.0 |
HPLC, fluorescence spectroscopy |
Jaime Villaverde 2005 |
[g-Cyclodextrin](1).[2-anthracenecarboxylic acid] |
2.26 |
|
|
20.0 |
UV-vis, NMR and circular dichroism spectroscopy |
Yoshihisa Inoue 2006 |
[g-Cyclodextrin](1).[2-anthracenecarboxylic acid] |
2.26 |
|
|
20.0 |
circular dichroism spectroscopy |
Yoshihisa Inoue 2006 |
[g-Cyclodextrin](0.5).[2-anthracenecarboxylic acid] |
4.75 |
|
|
20.0 |
UV-vis, NMR and circular dichroism spectroscopy |
Yoshihisa Inoue 2006 |
[g-Cyclodextrin](0.5).[2-anthracenecarboxylic acid] |
4.75 |
|
|
20.0 |
circular dichroism spectroscopy |
Yoshihisa Inoue 2006 |
[g-Cyclodextrin](1).[adamantane carboxylate] |
3.00 |
|
10.0 |
25.0 |
UV-vis spectroscopy |
Rita H. de Rossi 1995 |
[g-Cyclodextrin](1).[sodium perfluorooctanoate] |
2.81 |
|
10.0 |
25.0 |
UV-vis spectroscopy |
Rita H. de Rossi 1995 |
[g-Cyclodextrin](1).[2-(2’-hydroxyphenyl)benzimidazole] |
1.65 |
|
7.0 |
25.0 |
fluorescence spectroscopy |
Isiah M.Warner 1996 |
[g-Cyclodextrin](1).[2-(2¢-hydroxyphenyl)benzoxazole] |
2.15 |
|
7.0 |
25.0 |
fluorescence spectroscopy |
Isiah M.Warner 1996 |
[g-Cyclodextrin](1).[2-(2’-hydroxyphenyl)benzothiazole] |
2.21 |
|
7.0 |
25.0 |
fluorescence spectroscopy |
Isiah M.Warner 1996 |
[g-Cyclodextrin](1).[2-(2’-methoxyphenyl)benzothiazole] |
2.40 |
|
7.0 |
25.0 |
fluorescence spectroscopy |
Isiah M.Warner 1996 |
[g-Cyclodextrin](1).[calcichrome] |
2.63 |
2.15 |
|
25.0 |
NMR spectroscopy |
Bo-Long Poh 1996 |
[g-Cyclodextrin](1).[tert-butyl group on polymer chain] |
1.76 |
|
|
|
NMR spectroscopy |
Akira Harada 1997 |
[g-Cyclodextrin](1).[isooctyl group on polymer chain] |
1.71 |
|
|
|
NMR spectroscopy |
Akira Harada 1997 |
[g-Cyclodextrin](1).[dodecyl group on polymer chain] |
2.39 |
|
|
|
NMR spectroscopy |
Akira Harada 1997 |
[g-Cyclodextrin](1).[riboflavin 5'-(dihydrogen phosphate) monosodium salt] |
3.45 |
2.52 |
|
|
fluorescence spectroscopy |
Yannis L. Loukas 1997 |
[g-Cyclodextrin](1).[warfarin] |
2.28 |
|
9.5 |
25.0 |
fluorescence spectroscopy |
Mamoru Kamiya 1997 |
[g-Cyclodextrin](1).[1-anilino-8-naphthalenesulfonate ion] |
2.11 |
0.45 |
11.6 |
25.0 |
spectrofluorometry |
Oswald S.Tee 1996 |
[g-Cyclodextrin](1).[1-anilino-8-naphthalenesulfonate ion] |
3.10 |
|
|
25.0 |
NMR titration |
Oswald S.Tee 1996 |
[g-Cyclodextrin](1).[1-anilino-8-naphthalenesulfonate ion] |
2.44 |
|
|
25.0 |
fluorescence spectroscopy |
Oswald S.Tee 1996 |
[g-Cyclodextrin](1).[prednisolone] |
3.25 |
1.68 |
5.5 |
25.0 |
NMR spectroscopy |
Kim L.Larsen 2005 |
[g-Cyclodextrin](1).[prednisolone] |
3.51 |
|
|
25.0 |
NMR, UV-vis spectroscopy, X-ray diffraction |
Kim L.Larsen 2005 |
[g-Cyclodextrin](1).[6a-methyl prednisolone] |
3.40 |
1.98 |
5.5 |
25.0 |
NMR spectroscopy |
Kim L.Larsen 2005 |
[g-Cyclodextrin](1).[malic acid] |
0.23 |
-0.52 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[tartaric acid] |
0.28 |
|
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[maleic acid] |
0.32 |
-0.52 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[citric acid] |
0.40 |
0.04 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[iodid ion] |
0.86 |
0.23 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[perchlorate ion (ClO4-)] |
0.73 |
0.15 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[fulminate ion (CNO-)] |
1.68 |
0.83 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[thiocianate/rodanid ion (SCN-)] |
0.79 |
|
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[dichromate ion(Cr2O72-)] |
1.26 |
0.46 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[L-phenylalanine] |
0.18 |
-0.52 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[L-tryptophane] |
1.17 |
0.04 |
|
|
freezing point depression method, osmotic measurements |
Masahiko Suzuki 1993 |
[g-Cyclodextrin](1).[benzoate ion] |
0.48 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[2-methyl benzoate ion] |
0.85 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[3-methyl benzoate ion] |
0.78 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[4-methyl benzoate ion] |
0.90 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[2,4-dimethyl benzoate ion] |
0.90 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[2,5-dimethyl benzoate ion] |
0.78 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[3,5-dimethyl benzoate ion] |
0.85 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[3,5-dimethoxy benzoate ion] |
1.00 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[salicylate ion] |
1.11 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[3-phenyl propionate ion] |
0.85 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[4-tert-butyl benzoate ion] |
1.87 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[ibuprofen anion] |
1.83 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[1-adamantane carboxylate ion] |
1.62 |
|
|
25.0 |
capillary electrophoresis |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[1-adamantane carboxylate ion] |
3.48 |
|
|
25.0 |
microcalorimetry |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[1-adamantane carboxylate ion] |
2.43 |
0.95 |
|
25.0 |
spectrophotometry |
Wolfgang Zimmermann 1998 |
[g-Cyclodextrin](1).[palmoic acid] |
3.61 |
2.85 |
10.8 |
25.0 |
fluorescence spectroscopy, circular dichroism |
Koji Kano 1991 |
[g-Cyclodextrin](1).[2,2'-dihydroxy-1,1'-dinaphthylmethane] |
2.32 |
1.48 |
5.5 |
25.0 |
fluorescence spectroscopy, circular dichroism |
Koji Kano 1991 |
[g-Cyclodextrin](1).[3-hydroxy-2-naphthoic acid] |
2.10 |
1.00 |
5.5 |
25.0 |
fluorescence spectroscopy, circular dichroism |
Koji Kano 1991 |
[g-Cyclodextrin](0.5).[gentian violet] |
7.90 |
7.30 |
7.5 |
25.0 |
UV-vis spectroscopy |
David Díaz 1999 |
[g-Cyclodextrin](1).[gentian violet] |
1.03 |
-0.40 |
|
25.0 |
UV-vis spectroscopy |
David Díaz 1999 |
[g-Cyclodextrin](1).[1-adamantanol] |
4.41 |
|
6.4 |
20.0 |
electrochemical masurements, cyclic voltammetry |
Marcin Majda 2000 |
[g-Cyclodextrin](1).[1-adamantane carboxylate] |
3.48 |
|
|
25.0 |
pH titration |
Marcin Majda 2000 |
[g-Cyclodextrin](1).[nabumetone] |
3.46 |
2.60 |
|
15.0 |
fluorescence spectroscopy |
Nathir A.F. Al-Rawashdeh 2005 |
[g-Cyclodextrin](1).[nabumetone] |
3.34 |
2.00 |
|
25.0 |
fluorescence spectroscopy |
Nathir A.F. Al-Rawashdeh 2005 |
[g-Cyclodextrin](1).[nabumetone] |
3.23 |
2.00 |
|
35.0 |
fluorescence spectroscopy |
Nathir A.F. Al-Rawashdeh 2005 |
[g-Cyclodextrin](1).[nabumetone] |
3.08 |
2.00 |
|
45.0 |
fluorescence spectroscopy |
Nathir A.F. Al-Rawashdeh 2005 |
[g-Cyclodextrin](1).[adamantanecarboxylate] |
3.52 |
|
8.5 |
25.0 |
microcalorimetry, pH potentiometry |
Maurice R. Eftink 1985 |
[g-Cyclodextrin](1).[adamantanecarboxylate] |
3.52 |
|
4.08 |
25.0 |
microcalorimetry, pH potentiometry |
Maurice R. Eftink 1985 |
[g-Cyclodextrin](1).[adamantanecarboxylate] |
3.38 |
|
4.5 |
25.0 |
microcalorimetry, pH potentiometry |
Maurice R. Eftink 1985 |
[g-Cyclodextrin](1).[adamantanecarboxylic acid] |
2.70 |
|
7.22 |
25.0 |
microcalorimetry, pH potentiometry |
Maurice R. Eftink 1985 |
[g-Cyclodextrin](1).[adamantanecarboxylic acid] |
4.38 |
|
4.08 |
25.0 |
microcalorimetry, pH potentiometry |
Maurice R. Eftink 1985 |